Chemours Valuation
| CC Stock | USD 17.62 1.10 6.66% |
At this time, the firm appears to be overvalued. Chemours shows a prevailing Real Value of $16.13 per share. The current price of the firm is $17.62. Our model approximates the value of Chemours from analyzing the firm fundamentals such as return on equity of -0.67, and Profit Margin of (0.05) % as well as examining its technical indicators and probability of bankruptcy. Key fundamental drivers impacting Chemours' valuation include:
Price Book 7.6656 | Enterprise Value | Enterprise Value Ebitda 14.4226 | Price Sales 0.4001 | Forward PE 8.8106 |
Overvalued
Today
Please note that Chemours' price fluctuation is not too volatile at this time. Calculation of the real value of Chemours is based on 3 months time horizon. Increasing Chemours' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Chemours is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Chemours Stock. However, Chemours' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 17.62 | Real 16.13 | Target 16.33 | Hype 17.95 | Naive 15.31 |
The real value of Chemours Stock, also known as its intrinsic value, is the underlying worth of Chemours Company, which is reflected in its stock price. It is based on Chemours' financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Chemours' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Chemours Co helps investors to forecast how Chemours stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Chemours more accurately as focusing exclusively on Chemours' fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Chemours' intrinsic value based on its ongoing forecasts of Chemours' financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Chemours' closest peers. If more than one evaluation category is relevant for Chemours we suggest using both methods to arrive at a better estimate.
Chemours Cash |
|
Chemours Revenue by Product
Chemours Total Value Analysis
Chemours Co is currently forecasted to have takeover value of 6.09 B with market capitalization of 2.34 B, debt of 4.36 B, and cash on hands of 713 M. Please note that takeover value may be misleading and is a subject to accounting mistakes. We encourage investors to methodically examine all of the Chemours fundamentals before making investment evaluation based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
6.09 B | 2.34 B | 4.36 B | 713 M |
Chemours Investor Information
About 95.0% of the company shares are held by institutions such as insurance companies. The company has Price/Earnings To Growth (PEG) ratio of 1.67. Chemours recorded a loss per share of 2.13. The entity last dividend was issued on the 14th of November 2025. Based on the key indicators related to Chemours' liquidity, profitability, solvency, and operating efficiency, Chemours Co may be sliding down financialy. It has an above-average probability of going through some form of financial hardship next quarter.Chemours Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Chemours has an asset utilization ratio of 76.94 percent. This indicates that the Company is making $0.77 for each dollar of assets. An increasing asset utilization means that Chemours Co is more efficient with each dollar of assets it utilizes for everyday operations.Chemours Profitability Analysis
Based on Chemours' profitability indicators, Chemours' profitability may be sliding down. It has an above-average probability of reporting lower numbers next quarter. Profitability indicators assess Chemours' ability to earn profits and add value for shareholders.Net Income | First Reported 2012-12-31 | Previous Quarter -381 M | Current Value 60 M | Quarterly Volatility 208 M |
| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Gross Profit Margin | 0.26 | 0.23 |
|
|
For Chemours profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Chemours to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Chemours utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Chemours's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Chemours over time as well as its relative position and ranking within its peers.
Chemours Earnings per Share Projection vs Actual
The next projected EPS of Chemours is estimated to be 0.43185 with future projections ranging from a low of 0.345 to a high of 0.5375. Chemours' most recent 12-month trailing earnings per share (EPS TTM) is at -2.13. Please be aware that the consensus of earnings estimates for Chemours Co is based on EPS before non-recurring items and includes expenses related to employee stock options.Chemours Earnings Estimation Breakdown
The calculation of Chemours' earning per share is based on the data from the past 12 consecutive months, used for reporting the company's financial figures. The next projected EPS of Chemours is estimated to be 0.43185 with the future projection ranging from a low of 0.345 to a high of 0.5375. Please be aware that this consensus of annual earnings estimates for Chemours Co is based on EPS before non-recurring items and includes expenses related to employee stock options.Last Reported EPS
0.34 Lowest | Expected EPS | 0.54 Highest |
Chemours Earnings Projection Consensus
Suppose the current estimates of Chemours' value are higher than the current market price of the Chemours stock. In this case, investors may conclude that Chemours is overpriced and will exhibit bullish sentiment. On the other hand, if the present value is lower than the stock price, analysts may conclude that the market undervalues the equity. These scenarios may suggest that the market is not as efficient as it should be at the estimation time, and Chemours' stock will quickly adjusts to the new information provided by the consensus estimate.
| Number of Analysts | Historical Accuracy | Last Reported EPS | Estimated EPS for 31st of December 2026 | Current EPS (TTM) | |
| 9 | 62.49% | 0.0 | 0.43185 | -2.13 |
Chemours Ownership Allocation
Chemours holds a total of 149.89 Million outstanding shares. The majority of Chemours Co outstanding shares are owned by other corporate entities. These outside corporations are usually referred to as non-private investors looking to acquire positions in Chemours to benefit from reduced commissions. Consequently, institutional investors are subject to a different set of regulations than regular investors in Chemours. Please pay attention to any change in the institutional holdings of Chemours Co as this could imply that something significant has changed or is about to change at the company. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.Chemours Profitability Analysis
The company generated the yearly revenue of 5.78 B. Reported Net Income was 86 M with gross profit of 1.02 B.Chemours Past Distributions to stockholders
| 15th of December 2025 | ||
| 12th of September 2025 | ||
| 16th of June 2025 | ||
| 14th of March 2025 | ||
| 16th of December 2024 | ||
| 13th of September 2024 | ||
| 14th of June 2024 | ||
| 15th of March 2024 |
Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Chemours' worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Chemours and how it compares across the competition.
About Chemours Valuation
The stock valuation mechanism determines Chemours' current worth on a weekly basis. Our valuation model uses a comparative analysis of Chemours. We calculate exposure to Chemours's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Chemours's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 1 B | 1.2 B | |
| Pretax Profit Margin | 0.03 | 0.02 | |
| Operating Profit Margin | 0.09 | 0.11 | |
| Net Profit Margin | 0.02 | 0.02 | |
| Gross Profit Margin | 0.23 | 0.26 |
A single share of Chemours represents a small ownership stake in the entity. As a stockholder of Chemours, your percentage of company ownership is determined by dividing the number of shares you own by the total number of shares outstanding and then multiplying that amount by 100. Owning stock in a company generally confers both corporate voting rights and income from any dividends paid to the stock owner.
Chemours Dividends Analysis For Valuation
The current year's Dividend Payout Ratio is expected to grow to 1.63, whereas Dividends Paid is forecasted to decline to about 134.5 M. . At present, Chemours' Price Earnings Ratio is projected to decrease significantly based on the last few years of reporting.
| Last Reported | Projected for Next Year | ||
| Dividends Paid | 170.2 M | 134.5 M | |
| Dividend Yield | 0.07 | 0.04 | |
| Dividend Payout Ratio | 1.55 | 1.63 | |
| Dividend Paid And Capex Coverage Ratio | (1.43) | (1.36) |
There are various types of dividends Chemours can pay to its shareholders, and the actual value of the dividend is determined on a per-share basis. It is to be paid equally to all of Chemours shareholders on a specific date, known as the payable date. The cash dividend is the most common type of dividend payment - it is the payment of actual cash from Chemours Co directly to its shareholders. There are other types of dividends that companies can issue, such as stock dividends or asset dividends. When Chemours pays a dividend, it has no impact on its enterprise value. It does, however, lowers the Equity Value of Chemours by the value of the dividends paid out.
Chemours Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Common Stock Shares Outstanding | 150 M | |
| Quarterly Earnings Growth Y O Y | -0.646 | |
| Forward Price Earnings | 8.8106 |
Chemours Current Valuation Indicators
Valuation refers to the process of determining the present value of Chemours Co and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value Chemours we look at many different elements of the entity such as Chemours's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Chemours, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Chemours' valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Chemours' worth.Complementary Tools for Chemours Stock analysis
When running Chemours' price analysis, check to measure Chemours' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Chemours is operating at the current time. Most of Chemours' value examination focuses on studying past and present price action to predict the probability of Chemours' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Chemours' price. Additionally, you may evaluate how the addition of Chemours to your portfolios can decrease your overall portfolio volatility.
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets |